Skip to content

NEXIMMUNE, INC.: 10-Q filed 2021-11-12

What NEXIMMUNE, INC. reported in its quarterly report filed 2021-11-12 (fiscal Q3 2021): 43 published measures, 124 facts as tagged in accession 0001538210-21-000006.

This filing

Form
10-Q (quarterly report)
Filed
2021-11-12
Fiscal period
fiscal Q3 2021
Accession
0001538210-21-000006 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NEXIMMUNE, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-09-30104,541,707USD
At 2020-12-3111,301,070USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-09-307,432,547USD
At 2020-12-3127,055,262USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-09-3097,109,160USD
At 2021-06-30109,909,420USD
At 2020-12-31-69,374,941USD
At 2020-09-30-62,855,162USD
At 2020-06-30-54,562,092USD
At 2019-12-31-43,009,568USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-09-3037,256,427USD
At 2020-12-315,031,079USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-14,647,112USD92
2021-01-01 to 2021-09-30-35,375,910USD273
2020-07-01 to 2020-09-30-8,608,735USD92
2020-01-01 to 2020-09-30-21,854,768USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-34,346,678USD273
2020-01-01 to 2020-09-30-19,212,915USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2021-01-01 to 2021-09-301,834,709USD273
2020-01-01 to 2020-09-30638,857USD274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2021-07-01 to 2021-09-300USD92
2021-01-01 to 2021-09-300USD273
2020-07-01 to 2020-09-300USD92
2020-01-01 to 2020-09-300USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-09-30124,383,258USD273
2020-01-01 to 2020-09-3011,615,953USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-57,811,232USD273
2020-01-01 to 2020-09-30448,288USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-09-30-112,217,857USD
At 2020-12-31-77,582,005USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2021-07-01 to 2021-09-3022,653,410shares92
2021-01-01 to 2021-09-3019,335,170shares273
2020-07-01 to 2020-09-301,254,808shares92
2020-01-01 to 2020-09-301,254,724shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2021-07-01 to 2021-09-3022,653,410shares92
2021-01-01 to 2021-09-3019,335,170shares273
2020-07-01 to 2020-09-301,254,808shares92
2020-01-01 to 2020-09-301,254,724shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-0.65USD/shares92
2021-01-01 to 2021-09-30-1.85USD/shares273
2020-07-01 to 2020-09-30-7.52USD/shares92
2020-01-01 to 2020-09-30-19.38USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-0.65USD/shares92
2021-01-01 to 2021-09-30-1.85USD/shares273
2020-07-01 to 2020-09-30-7.52USD/shares92
2020-01-01 to 2020-09-30-19.38USD/shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2021-07-01 to 2021-09-300USD92
2021-01-01 to 2021-09-300USD273
2020-07-01 to 2020-09-300USD92
2020-01-01 to 2020-09-300USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-09-304,287,254USD
At 2020-12-312,885,260USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-01-01 to 2021-09-304,309,356USD273
2020-01-01 to 2020-09-30943,210USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-15,490,385USD92
2021-01-01 to 2021-09-30-37,723,608USD273
2020-07-01 to 2020-09-30-7,665,306USD92
2020-01-01 to 2020-09-30-20,800,537USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-09-3098,726,857USD
At 2020-12-318,392,437USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2021-07-01 to 2021-09-301,106USD92
2021-01-01 to 2021-09-30905,326USD273
2020-07-01 to 2020-09-30559,325USD92
2020-01-01 to 2020-09-30743,996USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-09-307,432,547USD
At 2020-12-3127,026,798USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-09-303,501,098USD
At 2020-12-312,760,129USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-07-01 to 2021-09-3015,490,385USD92
2021-01-01 to 2021-09-3037,723,608USD273
2020-07-01 to 2020-09-307,665,306USD92
2020-01-01 to 2020-09-3020,800,537USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2021-07-01 to 2021-09-3011,331,189USD92
2021-01-01 to 2021-09-3025,468,770USD273
2020-07-01 to 2020-09-304,913,055USD92
2020-01-01 to 2020-09-3013,394,483USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-09-3022,711,247shares
At 2020-12-311,256,609shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2021-09-3037,323,927USD
At 2020-12-315,098,579USD
At 2020-09-302,047,813USD
At 2019-12-319,196,487USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-09-30209,324,044USD
At 2020-12-318,206,938USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2021-09-30702USD
At 2020-12-310USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2021-09-306,334,142USD
At 2020-12-314,308,601USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2021-09-302,046,888USD
At 2020-12-311,423,341USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2021-09-301,527,596USD
At 2020-12-3123,373USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2021-09-300USD
At 2020-12-314,935USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2021-09-303,931,449USD
At 2020-12-312,603,027USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2021-09-305,416,575USD
At 2020-12-313,293,858USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-14,643,493USD92
2021-01-01 to 2021-09-30-35,375,208USD273
2020-07-01 to 2020-09-30-8,608,735USD92
2020-01-01 to 2020-09-30-21,855,274USD274

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-14,647,112USD92
2021-01-01 to 2021-09-30-35,753,472USD273
2020-07-01 to 2020-09-30-9,433,516USD92
2020-01-01 to 2020-09-30-24,311,181USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-304,159,196USD92
2021-01-01 to 2021-09-3012,254,838USD273
2020-07-01 to 2020-09-302,752,251USD92
2020-01-01 to 2020-09-307,406,054USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2021-01-01 to 2021-09-30627,043USD273
2020-01-01 to 2020-09-30448,108USD274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-19,095USD92
2021-01-01 to 2021-09-30-45,791USD273
2020-07-01 to 2020-09-3012,328USD92
2020-01-01 to 2020-09-3066,329USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2021-07-01 to 2021-09-30843,273USD92
2021-01-01 to 2021-09-302,347,698USD273
2020-07-01 to 2020-09-30-943,429USD92
2020-01-01 to 2020-09-30-1,054,231USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2021-01-01 to 2021-09-30457USD273
2020-01-01 to 2020-09-301,871USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-301,522,406USD273
2020-01-01 to 2020-09-30817,769USD274

Inspect the source

Entity
NEXIMMUNE, INC. / CIK 0001538210
Captured
SEC response SHA-256
fcbe0222b7b76241e4e7eb1c1e3cf5fc2288ab620da6b9d27249a8084fdbc63d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001538210.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))